Praxis Precision Medicines (PRAX) Short-term Investments (2024 - 2026)

Praxis Precision Medicines' Short-term Investments history runs 3 years deep, the most recent figure standing at $250.5 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 54.25% year-over-year to $250.5 million; the TTM figure through Mar 2026 stood at $250.5 million (up 54.25% YoY), while the FY2025 annual figure was $242.0 million, up 36.57% from the prior year.
• Short-term Investments for Q1 2026 stood at $250.5 million, up from $242.0 million in the prior quarter.
• The five-year high for Short-term Investments was $250.5 million in Q1 2026, with the low at $55.4 million in Q1 2024.
• The 3-year median for Short-term Investments is $177.2 million (2024), against an average of $171.6 million.
• Peak annual rise in Short-term Investments reached 192.99% in 2025, while the deepest fall reached 37.56% in 2025.
• Praxis Precision Medicines' Short-term Investments stood at $177.2 million in 2024, then soared by 36.57% to $242.0 million in 2025, then grew by 3.52% to $250.5 million in 2026.
• Business Quant data shows PRAX's Short-term Investments at $250.5 million in Q1 2026, $242.0 million in Q4 2025, and $117.6 million in Q3 2025.